Stay Updated On Crucial Trends To Chalk Positive Growth Curve

Market Research Reports by Industry

Reports by Industry

Research Reports in Oncology Drugs

Total Reports: 15

Prostate Cancer Therapeutics Market

The global prostate cancer therapeutics market outlook appears positive. Substantial progress has been made in prostate cancer androgen receptor targeting in the past 10 years. The best way to apply immunotherapy and radiopharmaceutical-based treatment in the clinic is yet unknown, but both have made strides.

Rep Id : TMRGL6562 | Published | Pharmaceutical | July 2022

Cancer Immunotherapy Market

Immunotherapy is a cancer treatment that improves the immune system's ability to fight cancer. It is a kind of biological treatment. Biological therapy makes use of compounds derived from biological creatures or lab-created copies of these substances.

Rep Id : TMRGL4312 | Published | Pharmaceutical | June 2022

Implantable Medical Devices Market

TMR’s report on the implantable medical devices market in the U.S. studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the implantable medical devices market in

Rep Id : TMRGL326 | Published | Pharmaceutical | April 2022

Basal Cell Carcinoma Treatment Market Report, 2017-2025

This report on the global basal cell carcinoma treatment market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary

Rep Id : TMRGL40139 | Published | Pharmaceutical | November 2021

Adult Malignant Glioma Therapeutics Market

This report studies the current as well as future prospects of the global adult malignant glioma therapeutics market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of malignant glioma therapeutics and new entrants planning to enter the market.

Rep Id : TMRGL13211 | Published | Pharmaceutical | November 2021

Breast Cancer Therapeutics Market Insights, 2015-2023

Changes in lifestyle and obesity are some of the key risk factors causing breast cancer. The incidence of the disease is more prevalent in women than in men, and is aggravated by the presence of several co-morbidity factors, with no clear causes. According to Breastcancer.org, a non-profit organization working on

Rep Id : TMRGL5678 | Published | Pharmaceutical | November 2021

Head and Neck Cancer Market

This report analyzes the current and future scenario of the global head and neck cancer market. Increase in patient population with head and neck cancer, growth of the pharmaceutical industry, improvement in health care infrastructure, and surge in the number of clinical trials are projected to be the major drivers

Rep Id : TMRGL22919 | Published | Pharmaceutical | October 2018

Osteoarthritis Drugs Market

This report analyzes the current and future scenario of the global osteoarthritis drugs market for the period 2018 to 2026. Rise in geriatric population, prevalence of obesity, high unmet medical needs, and rich pipeline are likely to be major drivers of the global osteoarthritis drugs market during the forecast period.

Rep Id : TMRGL47571 | Published | Pharmaceutical | August 2018

Anticancer Drugs Market

This report on the global anticancer drugs market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

Rep Id : TMRGL12458 | Published | Pharmaceutical | January 2018

Pneumococcal Vaccines Market

The prevention of disease through vaccination is one of the most cost-effective and safe ways. Pneumococcus is one of the leading causes of blood infection, pneumonia, sinusitis, meningitis, and otitis media.

Rep Id : TMRGL36536 | Published | Pharmaceutical | December 2017

Chronic Myelogenous Leukemia Treatment Market

Chronic Myelogenous Leukemia (CML) takes place when the bone marrow starts making too many white blood cells. This may affect red blood cells, white blood cells, and platelets. The first line treatment for CML in chronic phase is being largely treated with targeted drugs such as tyrosine kinase inhibitors (TKIs)

Rep Id : TMRGL34940 | Published | Pharmaceutical | November 2017

Rare Hematology Market

The global rare hematology market is expected to witness a healthy growth attributed to growing prevalence of blood related disorders. Surge in demand to conduct the diagnosis process at the early phase is expected to impact growth of the global rare hematology market significantly.

Rep Id : TMRGL34736 | Published | Pharmaceutical | November 2017

Oncology Biosimilars Market

The market for oncology biosimilars has just a few players and hence is consolidated in nature. Big shot players in the market are seen forging carefully-considered collaborations to expand their geographical footprints. A case in point is Dr. Reddy’s Laboratories, which entered into an agreement with TR-Pharm to strengthen its

Rep Id : TMRGL14696 | Published | Pharmaceutical | September 2017

Monoclonal Antibody Therapeutics Market Trends, 2016-2024

Monoclonal antibodies are a type of biological therapy used in the treatment serious conditions such as cancer, rheumatoid arthritis, Crohn’s diseases, psoriasis, osteoporosis, systemic lupus erythematous, and others. Monoclonal antibody are target specific in action by not affect the other cells of the body thus restores the immune system.

Rep Id : TMRGL18209 | Published | Pharmaceutical | January 2017

Circulating Tumor Cells (CTCs) Prognostic Technologies Market

This report provides the market analysis for various technologies and applications used for the enrichment and detection of circulating tumor cells (CTCs). The stakeholders of this report include companies and research institutes involved in the production of prognosis kits and research and development activities related to circulating tumor cells technologies

Rep Id : TMRGL2497 | Published | Pharmaceutical | June 2014

Load More

- 5 Reasons To Buy From TMR -

comprehensive coverage 100+ countries

Most comprehensive coverage 100+ countries, 2 million+ data points

post-sales support

Personalized pre-sales, on-boarding, and post-sales support

research methodology

Less assumption, more science a research methodology perfected through years of rigorous diligence

transparency in every minute details

True to its name, transparency in every minute details from research processes to financials

20% of Fortune

20% of Fortune 500 are our clients have worked with over 3000 SMEs

Copyright © Transparency Market Research, Inc. All Rights reserved

We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.

By clicking "Accept All", you consent to our use of cookies. Privacy Policy